Treatment patterns and outcomes among adults with immune thrombocytopenia receiving pharmaceutical second-line therapies: a retrospective cohort study using administrative claims data-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment patterns and outcomes among adults with immune thrombocytopenia receiving pharmaceutical second-line therapies: a retrospective cohort study using administrative claims data

Published:2024-03-25 Issue:5 Volume:40 Page:781-788
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Liang Yi¹,Rascati Karen¹²,Barner Jamie C.¹²,Lawson Kenneth A.¹²,Nair Radhika³

Affiliation:

1. Health Outcomes Division, College of Pharmacy, The University of Texas at Austin, Austin, TX, USA

2. TxCORE – Texas Center for Health Outcomes Research and Education, College of Pharmacy, The University of Texas at Austin, Austin, TX, USA

3. Intercept Pharmaceuticals, Morristown, NJ, USA

Funder

Platelet Disorder Support Association

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2024.2328653

Reference30 articles.

1. The pathogenesis of immune thrombocytopaenic purpura

2. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

3. Primary immune thrombocytopenia in US clinical practice: incidence and healthcare burden in first 12 months following diagnosis

4. Prevalence of primary immune thrombocytopenia and related healthcare resource utilization among Texas Medicaid beneficiaries

5. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP